A new allergic rhinitis therapy (MP29-02*) provides nasal and ocular symptom relief days faster than current firstline monotherapies

ABSTRACT:

SUBMITTER: Hellings P 

PROVIDER: S-EPMC4493498 | biostudies-literature | 2015 Jan

REPOSITORIES: biostudies-literature